Inventor · disambiguated record
Eva Dahlen
Also filed as: DAHLEN EVA · DAHLEN EVA MARIA · DAHLÉN EVA · DAHLÉN EVA MARIA
9 granted patents·3 pending applications·21 citations·filing 2008–2021
82Inventor score
Top patents by PatentIndex Score
12 records- 0183US9676862B2Anti-CD40 antibodies and methods of treating cancerELLMARK PETER BO JOAKIM·Filed 2012·Granted Jun 13, 2017·12 cites·18 claims
- 0280US11008396B2PolypeptidesALLIGATOR BIOSCIENCE AB·Filed 2016·Granted May 18, 2021·2 cites·10 claims
- 0373US8303945B2Mutants of interleukin-1 receptor antagonistDAHLEN EVA MARIA·Filed 2008·Granted Nov 6, 2012·7 cites·7 claims
- 0472US11780928B2PolypeptidesALLIGATOR BIOSCIENCE AB·Filed 2021·Granted Oct 10, 2023·0 cites·15 claims
- 0566US12173082B2Bispecific polypeptides against CD137ALLIGATOR BIOSCIENCE AB·Filed 2021·Granted Dec 24, 2024·0 cites·17 claims
- 0665US10774150B2PolypeptidesALLIGATOR BIOSCIENCE AB·Filed 2020·Granted Sep 15, 2020·0 cites·12 claims
- 0753US10640567B2Anti-CD40 antibodies and methods of treating cancer having CD40+ tumor cellsALLIGATOR BIOSCIENCE AB·Filed 2017·Granted May 5, 2020·0 cites·20 claims
- 0852US9834589B2CD86 variants with improved affinity for CTLA-4ALLIGATOR BIOSCIENCE AB·Filed 2014·Granted Dec 5, 2017·0 cites·6 claims
- 0943US2019169308A1Novel bispecific polypeptides against cd137ALLIGATOR BIOSCIENCE AB·Filed 2017·Application pending·0 cites
- 1041US9163072B2Mutants of interleukin-1 receptor antagonistDAHLÉN EVA MARIA·Filed 2012·Granted Oct 20, 2015·0 cites·9 claims
- 1139US2015368318A1Mutants of interleukin-1 receptor antagonist and uses thereofALLIGATOR BIOSCIENCE AB·Filed 2015·Application pending·0 cites
- 1238US2019161555A1Bispecific Antibodies Directed Against OX40 and a Tumor-Associated AntigenALLIGATOR BIOSCIENCE AB·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eva Dahlen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →